EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

The Prognostic Role of Perioperative Dexamethasone in Aseptic Revision Hip Arthroplasty—A Retrospective Cohort Study

Qiyu Xie, Zhixin Liao, Hong Xu, Wai Yao, Xuming Chen, Xufeng Wan, Duan Wang, Zongke Zhou iD

Orthopaedic Surgery · 2025

DOI: 10.1111/os.70113 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Orthopaedic Surgery, 2025. Verfasst von Qiyu Xie und 7 weiteren Autor:innen. Beteiligte Einrichtung: West China School of Medicine, Sichuan University, Chengdu, People's Republic of China. Hauptthemen laut MEDLINE: Arthroplasty, Replacement, Hip, Dexamethasone, Postoperative Pain, Postoperative Nausea and Vomiting. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, West China Hospital of Sichuan University 1·3·5 Discipline Excellence Development Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Aseptic hip revision arthroplasty often results in significant postoperative pain, inflammation, nausea, and vomiting. While perioperative dexamethasone has demonstrated benefits in primary hip arthroplasty, its efficacy and safety in revision procedures remain unclear. This study aims to evaluate the effects of perioperative dexamethasone on postoperative pain, inflammation, postoperative nausea and vomiting (PONV), and safety in aseptic hip revision.

Methods

A retrospective cohort study was conducted on 414 patients undergoing aseptic hip revision arthroplasty between 2008 and 2023. Patients were categorized into two groups: those receiving dexamethasone perioperatively ( n = 218) and a control group ( n = 196). Outcomes included Visual Analog Scale (VAS) pain scores, inflammation markers including C‐reactive protein (CRP) and interleukin‐6 (IL‐6), PONV incidence, analgesic and antiemetic usage, length of stay (LOS), and postoperative complications. Independent samples t ‐test or Mann–Whitney U test is applied to continuous variables based on normality, while chi‐square test or Fisher's exact test is used for categorical variables according to sample size.

Results

The dexamethasone group (average dose: 12.67 mg) exhibited significantly lower VAS scores ( p < 0.001) and reduced morphine use on postoperative days (PODs) 1–3. CRP (POD2: 40.60 mg/L vs. 111.66 mg/L) and IL‐6 levels (POD1: 31.85 pg/mL vs. 138.28 pg/mL) were significantly lower in the dexamethasone group (both p < 0.001). PONV incidence (28.4% vs. 40.81%) and antiemetic usage were reduced in the dexamethasone group. No significant differences were observed in LOS or postoperative complications between the two groups.

Conclusion

Perioperative low‐dose dexamethasone effectively mitigates pain, inflammation, and PONV in aseptic hip revision arthroplasty without increasing the risk of complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthroplasty, Replacement, HipDexamethasonePostoperative PainPostoperative Nausea and VomitingAnti-Inflammatory AgentsHumansRetrospective StudiesFemaleMaleMiddle AgedAgedReoperationPrognosisPain MeasurementPerioperative CareAntiemetics

Stichwörter der Autor:innen

aseptic hip revision arthroplastydexamethasoneinflammationpostoperative nausea and vomitingpostoperative pain

Substanzen

DexamethasoneAnti-Inflammatory AgentsAntiemetics

Autor:innen und Institutionen

  • West China School of Medicine, Sichuan University, Chengdu, People's Republic of China.
  • Department of Orthopedic Surgery and Orthopedic Research Institution, West China Hospital, Sichuan University, Chengdu, China.

ORCID-Profile: Zongke Zhou

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • West China Hospital of Sichuan University 1·3·5 Discipline Excellence Development Project

Zitieren

APA

Xie, Q., Liao, Z., Xu, H., Yao, W., Chen, X., Wan, X., Wang, D., & Zhou, Z. (2025). The Prognostic Role of Perioperative Dexamethasone in Aseptic Revision Hip Arthroplasty—A Retrospective Cohort Study. Orthopaedic Surgery. https://doi.org/10.1111/os.70113

Vancouver

Xie Q, Liao Z, Xu H, Yao W, Chen X, Wan X, et al. The Prognostic Role of Perioperative Dexamethasone in Aseptic Revision Hip Arthroplasty—A Retrospective Cohort Study. Orthopaedic Surgery. 2025. doi:10.1111/os.70113

BibTeX
@article{Xie2025,
  author = {Xie, Qiyu and Liao, Zhixin and Xu, Hong and Yao, Wai and Chen, Xuming and Wan, Xufeng and Wang, Duan and Zhou, Zongke},
  title = {The Prognostic Role of Perioperative Dexamethasone in Aseptic Revision Hip Arthroplasty—A Retrospective Cohort Study},
  journal = {Orthopaedic Surgery},
  year = {2025},
  doi = {10.1111/os.70113}
}
Kostenlos starten →